All Stories

  1. GlycoDiveR: A Modular R Framework to Analyze and Visualize Highly Dimensional Glycoproteomics Data
  2. GlycoDiveR: a modular R framework to analyze and visualize highly dimensional glycoproteomics data
  3. Understanding m / z Range Settings for MS/MS Scans: A Case Study with Intact Glycopeptides
  4. Profiling Glycoproteins Enriched by Multinanoparticle Protein Corona
  5. The protease Cathepsin K can debulk the cancer glycocalyx
  6. Extracting Informative Glycan-Specific Ions From Glycopeptide MS/MS Spectra With GlyCounter
  7. Sialoglycans on human T cells attenuate death programs executed through the Fas pathway
  8. Antibodies disrupt bacterial adhesion by ligand mimicry and allosteric interference
  9. Profiling glycoproteins enriched by multi-nanoparticle protein corona
  10. Understanding m/z range settings for MS/MS scans: a case study with intact glycopeptides
  11. Profiling glycoproteins enriched by surface-functionalized nanoparticles
  12. Sialoglycans on human T cells attenuate death programs executed through the Fas pathway
  13. Accelerating the stride toward functional glycoproteomics
  14. Improvements in Glycoproteomics through Architecture Changes to the Orbitrap Tribrid MS Platform
  15. Publisher Correction: irCLIP-RNP and Re-CLIP reveal patterns of dynamic protein assemblies on RNA
  16. Understanding m/z range settings for MS/MS scans: a case study with intact glycopeptides
  17. irCLIP-RNP and Re-CLIP reveal patterns of dynamic protein assemblies on RNA
  18. Extracting informative glycan-specific ions from glycopeptide MS/MS spectra with GlyCounter
  19. Comparative analysis of glycoproteomic software using a tailored glycan database
  20. Revisiting the Effect of Trypsin Digestion Buffers on Artificial Deamidation
  21. Antibodies disrupt bacterial adhesion by ligand mimicry and allosteric interference
  22. Autonomous Dissociation-type Selection for Glycoproteomics Using a Real-Time Library Search
  23. Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer
  24. “Comparative Analysis of Glycoproteomic Software Using a Tailored Glycan Database”
  25. Instrumentation at the Leading Edge of Proteomics
  26. Instrumentation at the leading edge of proteomics
  27. Instrumentation at the leading edge of proteomics
  28. Microglia Mediate Contact-Independent Neuronal Network Remodeling via Secreted Neuraminidase-3 Associated with Extracellular Vesicles
  29. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
  30. Galectin-3 does not interact with RNA directly
  31. Microglia mediate contact-independent neuronal pruning via secreted Neuraminidase-3 associated with extracellular vesicles
  32. Design of a mucin-selective protease for targeted degradation of cancer-associated mucins
  33. Organism-wide, cell-type-specific secretome mapping of exercise training in mice
  34. The microenvironment dictates glycocalyx construction and immune surveillance
  35. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity
  36. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  37. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  38. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  39. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  40. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  41. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  42. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  43. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  44. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  45. Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  46. Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  47. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  48. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  49. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  50. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  51. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  52. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  53. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  54. MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
  55. The 2022 Nobel Prize in Chemistry—sweet!
  56. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
  57. Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise
  58. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  59. Antibody-lectin chimeras for glyco-immune checkpoint blockade
  60. The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection
  61. Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
  62. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  63. Glycoproteomics
  64. Revealing the human mucinome
  65. Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
  66. Design of a mucin-selective protease for targeted degradation of cancer-associated mucins
  67. Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
  68. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  69. Practical Effects of Intramolecular Hydrogen Rearrangement in Electron Transfer Dissociation-Based Proteomics
  70. Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  71. Protocol for cell type-specific labeling, enrichment, and proteomic profiling of plasma proteins in mice
  72. The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C
  73. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
  74. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
  75. Revealing the human mucinome
  76. Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
  77. Modulation of immune cell reactivity with cis -binding Siglec agonists
  78. A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
  79. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
  80. Cell type-selective secretome profiling in vivo
  81. Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
  82. O-Pair Search with MetaMorpheus for O-glycopeptide characterization
  83. Cell type-selective secretome profiling in vivo
  84. Optical Fiber-Enabled Photoactivation of Peptides and Proteins
  85. Lysosome Targeting Chimeras (LYTACs) That Engage a Liver-Specific Asialoglycoprotein Receptor for Targeted Protein Degradation
  86. Lysosome-targeting chimaeras for degradation of extracellular proteins
  87. Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
  88. Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation
  89. Optimal Dissociation Methods Differ for N- and O-Glycopeptides
  90. Optimal Dissociation Methods Differ for N- and O-glycopeptides
  91. O-Pair Search with MetaMorpheus for O-glycopeptide Characterization
  92. Optimal Dissociation Methods Differ for N- and O-glycopeptides
  93. Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
  94. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  95. Broad and thematic remodeling of the surface glycoproteome on isogenic cells transformed with driving proliferative oncogenes
  96. Mutating stress-defense regulators in yeast improves biofuels engineering
  97. Interactive Peptide Spectral Annotator: A Versatile Web-Based Tool for Proteomic Applications
  98. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  99. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  100. Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis
  101. Rewired cellular signaling coordinates sugar and hypoxic responses for anaerobic xylose fermentation in yeast
  102. Top-Down Characterization of Proteins with Intact Disulfide Bonds Using Activated-Ion Electron Transfer Dissociation
  103. The Value of Activated Ion Electron Transfer Dissociation for High-Throughput Top-Down Characterization of Intact Proteins
  104. Improved Precursor Characterization for Data-Dependent Mass Spectrometry
  105. The Role of Electron Transfer Dissociation in Modern Proteomics
  106. Sequencing Larger Intact Proteins (30-70 kDa) with Activated Ion Electron Transfer Dissociation
  107. Activated Ion-Electron Transfer Dissociation Enables Comprehensive Top-Down Protein Fragmentation
  108. Negative Electron Transfer Dissociation Sequencing of Increasingly Sulfated Glycosaminoglycan Oligosaccharides on an Orbitrap Mass Spectrometer
  109. Implementation of Activated Ion Electron Transfer Dissociation on a Quadrupole-Orbitrap-Linear Ion Trap Hybrid Mass Spectrometer
  110. Phosphoproteomics with Activated Ion Electron Transfer Dissociation
  111. Sulfur Pentafluoride is a Preferred Reagent Cation for Negative Electron Transfer Dissociation
  112. Multi-omics Evidence for Inheritance of Energy Pathways in Red Blood Cells
  113. Full-Featured Search Algorithm for Negative Electron-Transfer Dissociation
  114. Genome Sequence and Analysis of a Stress-Tolerant, Wild-Derived Strain of Saccharomyces cerevisiae Used in Biofuels Research
  115. Proteomics Moves into the Fast Lane
  116. Mitochondrial protein hyperacetylation in the failing heart
  117. Enhanced Dissociation of Intact Proteins with High Capacity Electron Transfer Dissociation
  118. Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling
  119. The Negative Mode Proteome with Activated Ion Negative Electron Transfer Dissociation (AI-NETD)
  120. A Calibration Routine for Efficient ETD in Large-Scale Proteomics
  121. Activated Ion Electron Transfer Dissociation for Improved Fragmentation of Intact Proteins
  122. Coupling Capillary Zone Electrophoresis with Electron Transfer Dissociation and Activated Ion Electron Transfer Dissociation for Top-Down Proteomics
  123. Neutron-Encoded Mass Signatures for Quantitative Top-Down Proteomics